Langerhans cell sarcoma of the head and neck
详细信息 查看全文
- 作者：James E.F. Howarda ; 1 ; j.howard4@nhs.net" class="auth_mail" title="E-mail the corresponding authorAuthor Vitae ; Liam Mastersona ; b ; 1Author Vitae ; Raghav C. Dwivedia ; 1Author Vitae ; Piyush JaniaAuthor Vitae
- 关键词：Langerhans cell sarcoma ; Head and neck ; Prognosis ; Management
- 刊名：Critical Reviews in Oncology and Hematology
- 出版年：2016
- 出版时间：March 2016
- 年：2016
- 卷：99
- 期：Complete
- 页码：180-188
- 全文大小：1263 K
文摘
- •
Mean disease specific survival for head and neck cohort 20.5 months (SE ± 5.1).
- •
Head and neck disease appears to present later and with more disseminated disease.
- •
No significant difference in survival between head and neck cohort and remainder.
- •
Surgery is mainstay for local disease but clear margins not guarantee of clearance.
- •
Bone marrow transplantation is only effective treatment for disseminated disease.